|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.115 GBX | -4.17% |
|
-43.90% | -81.60% |
| 31/05 | Oxford Cannabinoid Technologies Drops Matched Bargain Facility Plans Ahead of Delisting | MT |
| 17/05 | Oxford Cannabinoid says it remains bound by Takeover Code | AN |
(via NewsDirect)
Sowemimo-Coker highlights the ongoing work on four drug development programs, including awaiting approval from MHRA for the lead program targeting chemotherapy induced peripheral neuropathy.
+44 20 7989 0813
uk@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| -81.60% | 15.98L | |
| +55.70% | 5.93TCr | |
| +41.08% | 4.02TCr | |
| -5.39% | 3.99TCr | |
| -5.56% | 2.86TCr | |
| +16.46% | 2.73TCr | |
| -20.56% | 1.92TCr | |
| +33.03% | 1.26TCr | |
| +25.85% | 1.23TCr | |
| +2.72% | 1.25TCr |
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC 
